Dr Mark Rafferty and Dr Matthew Wilson, consultant haematologists at the Beatson West of Scotland Cancer Centre in Glasgow discuss real word data, prospective clinical trial data and therapy and treatment options in the relapsed refractory Diffuse Large B Cell Lymphoma (DLBCL) space and review some of the key abstracts presented from ASH 2023 whilst addressing some of the key takeaways/challenges from the data.
Only to be shared with relevant UK haematology healthcare professionals.
CPD® Accreditation
To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.
Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.
